22nd Century Group Inc (NASDAQ: XXII) announced that it is granted Food and Drug Administration (FDA) approval to market and sell its VLN® King and VLN®...
AusCann Group Holdings recently announced its progress in Q2 F21. The company remains well-funded with a 13.7 million cash flow in Q2 F21. Operating expenses came to...
The revolution of research supporting the health benefits of CBD has been remarkable. From what we’ve seen, CBD, when consumed as a supplement or alternative treatment...